Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 6 |
GO:0043226 | organelle | 2 | 6 |
GO:0043227 | membrane-bounded organelle | 3 | 6 |
GO:0043229 | intracellular organelle | 3 | 6 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 4 | 1 |
GO:0005849 | mRNA cleavage factor complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AKC3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006378 | mRNA polyadenylation | 7 | 1 |
GO:0006379 | mRNA cleavage | 7 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0031123 | RNA 3'-end processing | 7 | 1 |
GO:0031124 | mRNA 3'-end processing | 8 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 1 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 1 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 8 | 1 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 9 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 343 | 347 | PF00656 | 0.822 |
CLV_PCSK_KEX2_1 | 357 | 359 | PF00082 | 0.722 |
CLV_PCSK_KEX2_1 | 72 | 74 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 357 | 359 | PF00082 | 0.722 |
CLV_PCSK_PC1ET2_1 | 72 | 74 | PF00082 | 0.411 |
CLV_PCSK_PC7_1 | 353 | 359 | PF00082 | 0.719 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.669 |
DOC_CKS1_1 | 292 | 297 | PF01111 | 0.719 |
DOC_CYCLIN_yCln2_LP_2 | 316 | 319 | PF00134 | 0.668 |
DOC_PP2B_LxvP_1 | 316 | 319 | PF13499 | 0.668 |
DOC_PP4_FxxP_1 | 352 | 355 | PF00568 | 0.724 |
DOC_PP4_MxPP_1 | 245 | 248 | PF00568 | 0.512 |
DOC_WW_Pin1_4 | 291 | 296 | PF00397 | 0.721 |
LIG_14-3-3_CanoR_1 | 211 | 217 | PF00244 | 0.347 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.645 |
LIG_BRCT_BRCA1_1 | 82 | 86 | PF00533 | 0.389 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.546 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.767 |
LIG_Integrin_RGD_1 | 223 | 225 | PF01839 | 0.383 |
LIG_LIR_Apic_2 | 350 | 355 | PF02991 | 0.829 |
LIG_LIR_Nem_3 | 83 | 88 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 92 | 98 | PF02991 | 0.413 |
LIG_MLH1_MIPbox_1 | 82 | 86 | PF16413 | 0.389 |
LIG_Pex14_2 | 86 | 90 | PF04695 | 0.411 |
LIG_PTB_Apo_2 | 202 | 209 | PF02174 | 0.623 |
LIG_PTB_Apo_2 | 84 | 91 | PF02174 | 0.411 |
LIG_PTB_Phospho_1 | 202 | 208 | PF10480 | 0.637 |
LIG_SH2_CRK | 183 | 187 | PF00017 | 0.828 |
LIG_SH2_CRK | 293 | 297 | PF00017 | 0.684 |
LIG_SH2_GRB2like | 85 | 88 | PF00017 | 0.411 |
LIG_SH2_NCK_1 | 293 | 297 | PF00017 | 0.804 |
LIG_SH2_SRC | 65 | 68 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.513 |
LIG_SH2_STAT3 | 171 | 174 | PF00017 | 0.824 |
LIG_SH2_STAT3 | 367 | 370 | PF00017 | 0.709 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.804 |
LIG_SH2_STAT5 | 315 | 318 | PF00017 | 0.713 |
LIG_SH2_STAT5 | 85 | 88 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.411 |
LIG_SH3_1 | 183 | 189 | PF00018 | 0.819 |
LIG_SH3_1 | 292 | 298 | PF00018 | 0.809 |
LIG_SH3_1 | 353 | 359 | PF00018 | 0.821 |
LIG_SH3_3 | 183 | 189 | PF00018 | 0.819 |
LIG_SH3_3 | 241 | 247 | PF00018 | 0.815 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.767 |
LIG_SH3_3 | 334 | 340 | PF00018 | 0.693 |
LIG_SH3_3 | 353 | 359 | PF00018 | 0.767 |
LIG_SH3_3 | 363 | 369 | PF00018 | 0.660 |
LIG_SUMO_SIM_anti_2 | 66 | 71 | PF11976 | 0.513 |
LIG_TRAF2_1 | 100 | 103 | PF00917 | 0.513 |
LIG_TRAF2_1 | 131 | 134 | PF00917 | 0.651 |
MOD_CK1_1 | 59 | 65 | PF00069 | 0.614 |
MOD_CK2_1 | 212 | 218 | PF00069 | 0.347 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.707 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.797 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.799 |
MOD_GlcNHglycan | 349 | 352 | PF01048 | 0.704 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.645 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.627 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.455 |
MOD_NEK2_1 | 212 | 217 | PF00069 | 0.347 |
MOD_NEK2_1 | 268 | 273 | PF00069 | 0.578 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.605 |
MOD_Plk_1 | 91 | 97 | PF00069 | 0.411 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.605 |
MOD_ProDKin_1 | 291 | 297 | PF00069 | 0.720 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.411 |
TRG_NES_CRM1_1 | 37 | 51 | PF08389 | 0.635 |
TRG_NLS_MonoCore_2 | 356 | 361 | PF00514 | 0.824 |
TRG_NLS_MonoExtC_3 | 356 | 362 | PF00514 | 0.722 |
TRG_NLS_MonoExtN_4 | 355 | 361 | PF00514 | 0.720 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5N7 | Leptomonas seymouri | 53% | 100% |
A0A3S5H5G4 | Leishmania donovani | 87% | 100% |
A4H465 | Leishmania braziliensis | 77% | 94% |
A4HSD3 | Leishmania infantum | 87% | 100% |
Q4QJI4 | Leishmania major | 86% | 98% |